Phase 2B Study to Evaluate the Efficacy of Bentracimab (PB2452) in Reversal of Ticagrelor in Subjects Aged 50-80 Years Old
Clinical trial NCT04122170 · COMPLETED
Trial details
- NCT number
- NCT04122170
- Sponsor
- SFJ Pharmaceuticals, Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-09-24
- Primary completion
- 2021-09-01
- Enrollment
- 207
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.